With the second wave of COVID-19 gaining strength, researchers are in a race against time to find a treatment or a vaccine. One international team of scientists from IBM Research and Oxford University is trying to design molecules that would interfere with the molecular machinery of coronavirus, the virus that triggers the disease. If successful, such molecules could become the basis of a new drug to treat or slow COVID-19 infections.